Alan Skarbnik

1PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Apr 04, 2018
A phase 1 study of lenalidomide and ibrutinib in combination with rituximab in relapsed and refractory CLL.

Chaitra Ujjani, Hongkun Wang, Alan Skarbnik

Pageof 1